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Abstract
Background: The purpose of this prospective study was to evaluate the donor site morbidity in
patients who have undergone oral mucosa graft urethroplasty for stricture of the urethra. The
impact of smoking and oral consumption of tobacco and/or paan masala on the donor site was also
assessed. This study is probably the first of its kind where the affect of smoking, paan masala and
tobacco chewing on the donor site morbidity has been documented.
Methods: Forty-eight patients suffering from stricture of the urethra underwent oral mucosa graft
urethroplasty between July 2005 and December 2007. The patients were divided into two groups
(users or non-users) based on tobacco consumption and oral hygiene. The donor site was
evaluated at frequent intervals for pain, swelling, numbness, bleeding, salivation and tightness of
mouth.
Results: Donor site morbidity was more in users with poor oral hygiene. Pain scores were higher
amongst the users and the morbidity persisted longer in the users compared to non-users with
good oral hygiene.
Conclusion: Patients who consume tobacco and have poor oral hygiene should be warned
regarding poorer outcomes after oral mucosa graft urethroplasty.
Background
Consumption of paan (betel leaves) or paan masala (dried
mixture of betel leaves with areca nut and slaked lime
which is consumed with or without tobacco along with
other condiments) is one of the unique social customs
prevalent in South - East Asia. [1,2] Unfortunately this
habit leads to deterioration in the quality of oral mucosa.
Many of the patients, who visit this institute for treatment,
consume tobacco in various forms and/or smoke. The
quality of oral mucosa is compromised by the consump-
tion of tobacco and smoking. [1-4] This may lead to
increased donor site morbidity after oral mucosa graft har-
vest.
The purpose of this study was to evaluate the donor site
morbidity in patients who underwent oral mucosa graft
urethroplasty (OMGU) for stricture of the urethra. This
prospective study is probably the first of its kind where the
impact of smoking, tobacco chewing and paan masala con-
sumption on donor site morbidity is being documented.
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A prospective study was performed which included 48
patients who underwent OMGU between July 2005 and
December 2007. The last follow-up of these patients was
till June 2008. Written informed consent was obtained
from all the patients included in this study. Ethical clear-
ance for this study was obtained from the institutional
ethics committee and was in accordance with the Declara-
tion of Helsinki. Patients were divided into two groups -
users - those who consumed tobacco in any form and had
a poor oral hygiene and non-users - those who did not
consumed tobacco in any form and had a good oral
hygiene. General data of all the patients e.g. name, age,
sex, address and phone number were recorded for the pur-
pose of identification and correspondence. Routine labo-
ratory and specific radiological evaluation was performed
prior to surgery.
Oral hygiene was inspected by the authors and those with
poor oral hygiene were sent to the dental department for
further opinion. Graft from these patients was only har-
vested if the dental department cleared these patients for
OMGU. Distribution of the patients according to their
type of addiction is mentioned in Table 1. Intra-operative
variables related to the donor site are mentioned in Table
2. Duration of exposure to tobacco was assessed in the
users and documented in Table 3. Donor site morbidity at
48 hours, at 1 week, at 1 month, at 6 months and at 1 year
respectively was the outcome considered for this study.
Parameters used were post-operative bleeding, pain,
swelling, tightness, numbness or more than one of the
above mentioned morbidities (Table 4). Visual analogue
scale (VAS) was used to compare the pain score between
the two groups.
Procedure of graft harvest
Patients are instructed to use a mouthwash containing
chlorhexidine in the pre-operative period. All the patients
receive intra-operative antibiotics (Ceftriaxone and Sul-
bactam combination, Amikacin and Metronidazole)
intravenously before the oral mucosa is excised. Initially
12 patients were operated under general anesthesia (nasal
or oral intubation) but at present the graft is harvested
under local analgesia according to our technique [5] and
all the patients are operated under regional anesthesia
(epidural or spinal). [6,7] The patients are counseled
regarding the graft harvest in the pre-operative period and
any queries raised by them regarding the procedure is
answered. This helps as the patients cooperate better dur-
ing the graft harvest. Two surgical teams work simultane-
ously, each having its own set of instruments.
In the majority, the graft is excised from the cheek; the
donor site was stitched in the initial few cases (Table 2)
but now it is left unstitched as a routine practice. [8-10]
Donor site is packed with a gauze piece soaked in adrena-
line and lignocaine. The oral pack is removed in the
evening and the patient is asked to rinse his mouth with
cold water and dilute mouthwash. The cavity is inspected
for any bleeding and the patient is asked to start cold oral
liquids in the evening. In a day or two the patient is
advised to shift to semi-solid, non-spicy diet and can con-
sume normal diet as soon as he can tolerate it.
Phone calls and letters were used to enquire about the
general well being of the patients. Even though only
42.1% of the patients responded to phone calls while
54% responded to the letter; still the majority came for
follow-up irrespective of the phone calls or letters. A pro-
forma was prepared at the time of admission, which doc-
umented all the raw data. Follow-up data was collected by
Table 1: Distribution of users according to the type of tobacco consumption
Type of addiction Number of patients Percentage (%)
Paan masala 3 10.7
Tobacco chewing 3 10.7
Smoking 3 10.7
Paan Masala with tobacco chewing 6 21.4
Paan Masala with smoking 4 14.3
Tobacco chewing and smoking 3 10.7
Paan Masala with tobacco chewing and smoking 6 21.4
Total no. of addicts 28 100.0Page 2 of 7
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cance and meaning of the questions and asked the ques-
tions in Hindi language which is the spoken language in
the northern India.
Statistical Analysis
The data was entered in the MS-Excel computer program
and all the analyses were carried out using SPSS (Ver.15.0)
statistical program. The mean and standard deviations
were calculated for continuous variables such as age, dif-
ferent lengths variables and proportions (percentages)
were calculated for discrete variables.
The Chi-square test was used to compare dichotomous/
categorical variables.
The paired t-test was used to detect significance from base-
line value to follow-up time in case of continuous varia-
bles and unpaired t-test was used to detect the difference
between two continuous variables.
Table 2: Graft harvest details
Indicators Variable Users Non-users
Type of graft Patch 28 20
Donor site Only One Cheek 14 10
Both Cheeks only 11 7
Both Cheeks + Tongue 2 1
Both Cheeks + Lower Lip 1 2
Total 28 20
Donor site treatment following graft Harvest Unstitched 24 16
Stitched 4 4
Total 28 20
Table 3: Distribution of users according to the duration of exposure to tobacco
Type of addiction Number of patients Exposure for 5 years or 
less
Exposure for more than 5 
but less than 10 years
Exposure for more than 
10 years
Paan masala 3 1 1 1
Tobacco chewing 3 1 1 1
Smoking 3 1 1 1
Paan Masala with tobacco 
chewing
6 3 2 1
Paan Masala with smoking 4 2 1 1
Tobacco chewing and 
smoking
3 1 1 1
Paan Masala with tobacco 
chewing and smoking
6 4 1 1
No. of addicts 28 (Total) 13 8 7Page 3 of 7
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data and all the continuous parameters were found to be
normally distributed. Hence, the parametric test is being
used for these parameters. The p-value < 0.05 was consid-
ered as significant.
Results
The post-operative follow-up of these 48 patients at one
month was 100% since all the patients came back for cath-
eter removal and all had completed their follow-up of 1
month. Following that 3 patients (2 users and 1 non-user)
were lost to follow-up at 6 monthly follow up and at 1
year follow-up 6 patients (4 users and 2 non-users) could
not be accounted for. So further follow-up was assessed in
these 42 patients; donor site morbidity at 6 months was
assessed in 32 patients and 1 year follow-up in 24 of these
patients who matured to that stage of follow-up at that
given time.
Symptoms related to donor site were assessed within 48
hours of surgery, then at 1 week, 1 month, 6 months and
1 year after the surgery (Table 4).
Eleven patients had co-morbid conditions prior to the sur-
gery but that did not impact the donor site morbidity dur-
ing intra-operative or post-operative period. Intra-
operative complications related to the donor site was rare
- one user patient with unstable dentures had tooth dis-
lodgement during oral intubation.
The mean age of all the patients (n = 48) was 36.60 ±
16.93 years (range 12 - 72 years) while that of the users (n
= 28) was 40.24 ± 14.68 (range 22 - 72 years) and non -
users (n = 20) was 32 ± 18.24 (range 12 - 68 years). Mean
follow-up of these patients was 18.2 months (range 6 - 36
months). Duration of disease in all the patients (n = 48)
was 5.77 ± 4.96 years (range 4 months - 15 years) and was
similar between users and non-users.
The stricture length (n = 48) was 9.88 ± 5.21 cm (range
2.00 - 17.80 cm). The graft length (n = 48) was 10.42 ±
5.12 cm (range 2.50 - 18.00 cm) and the graft width (n =
48) was 2.62 ± 0.18 cm (range 2.30 - 3.10 cm). The meas-
urements were similar between the users and the non-
users.
Donor site morbidity was observed in most of the patients
in both the groups at 48 hours; primary symptom being
pain followed by swelling, numbness and difficulty in
opening the mouth. Post-operative bleeding was more in
users as compared to non-users at 48 hours and persisted
in 2 of the users even at 1 week while the non-users recov-
ered quickly from this morbidity. Pain at the harvest site
was more in users at 48 hours and persisted for a longer
Table 4: Donor site morbidity at different time intervals during follow up
Symptoms
Duration of follow up At 48 hours At 1 week At 1 month At 6 months At 1 year
Users Non-users Users Non-users Users Non-users Users Non-users Users Non-users
Postoperative bleeding from 
the donor site
8 2 2 0 0 0 0 0 0 0
Pain at the graft harvest site 22 12 16 6 9 2 4 1 2 0
Swelling of the graft harvest 
site
16 4 10 1 4 0 2 0 0 0
Tightness of mouth 
(difficulty in opening the 
mouth)
9 2 5 2 4 1 3 0 2 0
Numbness of the graft harvest 
site
7 4 7 2 6 1 5 1 5 0
More than one morbidity co-
existing in the same patient
17 6 12 3 7 0 5 0 3 0
Patients having no morbidity 4 6 8 14 14 16 14 11 9 10
Total 28 20 28 20 28 20 19 13 14 10Page 4 of 7
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Swelling occurred in the users but subsided after 1 month
and only 2 users had swelling at 6 month follow-up. Dif-
ficulty in mouth opening and numbness was also more
common amongst users and those with poor hygiene and
persisted for a very long time. Users were more prone to
multiple oral morbidities. As the time interval increased
most of the symptoms subsided. Non-users had lower
pain scores and faster recovery compared to the users
(Table 4).
Differences in oral morbidity between users and non-
users were not statistically significant.
Discussion
Patients in our study had increased donor site morbidity
and poor oral recovery if the oral hygiene was compro-
mised to begin with. Even though a few western studies
have documented both short and long term donor site
morbidity but they have not focused upon oral hygiene or
tobacco consumption in any form.
Wood et al. [11] assessed the medium and long-term com-
plications via a patient postal questionnaire. In their
study, 83% patients experienced postoperative pain at the
site of graft harvest. Perioral numbness was noted in their
study in 68% of patients, which persisted in 26% at or
beyond 6 months of follow-up. Surprisingly, pain was
unrelated to size of graft harvest in that study. In our
study, patients with a longer or bilateral cheek graft har-
vest had higher pain scores within the user as well as the
non-user group; users had higher pain scores overall and
for longer period as mentioned previously.
In another study, Dublin et al. [12] found that in the post-
operative period the major symptoms were pain, numb-
ness and tightness of the mouth. In their patients, the
donor site was sutured which probably led to more pain.
Our patients had pain but it subsided quickly because the
donor site was left unstitched in 83.3% of the patients.
Jang et al. [13] compared post-operative intraoral morbid-
ity after graft harvest from the lower lip and inner cheek.
At a longer follow-up, patients whose grafts were har-
vested from the lower lip had more persistent discomfort,
salivary flow changes, and neurosensory deficits than
those with cheek harvest. We harvested graft from the
lower lip in 3 patients only (1 user and 2 non-users)
resulting in lower level of morbidity in non-users. In a
similar study Kamp et al. [14] evaluated 24 patients and
found that graft harvesting from the lower lip led to signif-
icantly prolonged discomfort for the patients. These stud-
ies reiterate our view that cheek is the best site for oral
mucosa harvest since problems like salivary flow changes
or cosmetic deformity are not encountered in graft harvest
from the cheek as compared to lower lip [15].
Nelson et al. [15] also support the view that cheek is the
better option for graft harvest and stated that most com-
mon complaint in their patients was cosmetic and none of
the patients whose oral graft harvest site was limited to the
cheek mucosa (as opposed to the lip) had cosmetic com-
plaints. According to the authors, there was no difference
between patients whose donor site was closed primarily
or allowed to re-epithelize secondarily contraindicates
our view that donor site should not be stitched since it
causes less pain when left unstitched.
Fabbroni et al. [16] assessed the morbidity at the donor
site and recorded any problems related to injury to the lin-
gual and mental nerves, symptoms of obstruction of the
parotid duct, and trismus but observed only four early
complaints of mild trismus and one late complaint. This
study again confirms our observations that post-operative
donor site morbidity is limited to a small percentage of
patients. It was observed in 20% of non-users and in 50%
of users at 1 month; 15.4% of non-users and 26% of users
at 6 months and 35.7% of users and 0.0% of non-users at
1 year. With the passage of time, most of the patients had
milder symptoms. Percentage of users with donor site
morbidity was more at 1 year as compared to that at 6
months perhaps due to the fact that the number of users
who were recovering better did not come for follow up
compared to those who still had co-morbidities.
Markiewicz et al. [17] reviewed the literature regarding
complications associated with the donor site and found
that the most frequent complications at mucosal harvest
sites were scarring and contracture which might have been
due to the fact that earlier all donor sites were stitched. We
did not encounter the above mentioned problems since
we left the donor site unstitched in 83.3% of patients as
stated earlier.
Dubey et al. [18,19] in two separate studies mentioned
donor site morbidity in Indian patients. According to the
authors, oral complications in the buccal mucosa urethro-
plasty group were few and of short term duration. Unlike
our study, the description of donor site morbidity was
brief and did not take the oral hygiene into account.
In a recent study, Castagnetti et al. [20] reported short
term and long term retrospective assessment of donor site
morbidity in a heterogeneous group of patients who
underwent oral mucosa graft harvest. At long term assess-
ment 28% of patients had perioral sensory deficit. This
deficit was seldom perceived by the patients and was only
reported if the oral surgeon examined them. From this
study we can infer that long term morbidity after graft har-Page 5 of 7
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site at 6 months amongst users and non-users was 26.3%
and 7.7% respectively and that at 1 year was 35.7% and
0.0% respectively. The reason why percentage of numb-
ness increased with increasing time interval is perhaps due
to the fact that the patient can appreciate numbness better
once pain and swelling subside. The other reason as men-
tioned above is due to more of such patients coming for
follow-up compared to those who were perhaps getting
better.
The weakness in our study is that it does not have a long
term data and the patient population is small due to
which the results of this study failed to reach any statistical
significance. Since it is rare to find a person who chews
tobacco or paan masala and smokes and still has a good
oral hygiene; we have not divided the patients further into
two more groups e.g. non-users with poor hygiene and
users with good hygiene due to small number of patients
in our study. Nonetheless, we accept this as a limitation of
our study. Since oral hygiene of the patient was initially
inspected by us and we then decided to refer the patients
to the dental department; this step might have introduced
a bias in the patient selection and is another limitation of
this study. Another limitation of this study could be due
to the use of chlorhexidine mouthwash in the pre-opera-
tive period which could have reduced the degree of local
inflammation, improved the condition of oral mucosa
and thus influenced the outcome of this study by reducing
the morbidity. We also believe that it is highly unlikely
since the mouthwash was used for a short time in the pre-
operative period and majority of the patients were con-
suming tobacco for a very long period of time.
The strength of this study is that it is a prospective study
and adds a new dimension to the donor site morbidity in
terms of oral hygiene and tobacco consumption. The
duration of exposure to tobacco has also been accounted
for in our study and the patients have been divided in two
groups based on exposure to tobacco.
Conclusion
In OMGU, donor site morbidity needs to be documented.
Patients having poor oral hygiene and those consuming
tobacco should be cautioned regarding increased donor
site morbidity. A future study might give some indication
whether patients having poor oral hygiene or on the bor-
derline can be prepared better with chlorhexidine mouth-
wash or any other medication and made more acceptable
for OMGU. This might expand the indication of OMGU
and provide benefit to more patients. More studies (per-
haps of longer duration) need to be published which
focus on the donor site morbidity in context of tobacco
chewing and smoking to reach a valid conclusion.
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